Presepsin for pre-operative prediction of major adverse cardiovascular events in coronary heart disease patients undergoing noncardiac surgery: Post hoc analysis of the Leukocytes and Cardiovascular Peri-operative Events-2 (LeukoCAPE-2) Study
CONCLUSION
Increased pre-operative presepsin independently predicted 30-day MACCE in CAD patients undergoing major noncardiac surgery. Complementing cardiovascular risk prediction by inflammatory biomarkers, such as presepsin, offers potential to improve peri-operative care. However, as prediction accuracy of presepsin was only moderate, further validation studies are needed.
TRIAL REGISTRATION
Clinicaltrials.gov: NCT03105427.
Source: European Journal of Anaesthesiology - Category: Anesthesiology Tags: Cardiac anaesthesia Source Type: research
More News: Anesthesia | Anesthesiology | Brain | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Coronary Heart Disease | Heart | Heart Attack | Heart Disease | Neurology | Stroke | Study